TILT Biotherapeutics is based in Helsinki, Finland. It has raised $78M in total funding. Latest round: Series B.
TILT Biotherapeutics is based in Helsinki, Finland. TILT Biotherapeutics has raised $78M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in May 2025. The round record for TILT Biotherapeutics runs through 2025; nothing later has been disclosed. Investors on record include European Innovation Council (EIC) Fund, Lifeline Ventures, Finnish Industry Investment (TESI), Stephen Industries Inc Oy, Springvest, Business Finland and 1 others. 7 distinct backers are named across the disclosed rounds.
Totals shown for TILT Biotherapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Helsinki and the investors behind them below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026